Royal DSM N.V. today provides the investment community with
comparative quarterly figures for 2008 and Q1 2009.
These comparative figures reflect the reclassification of DSM Energy
and Stamicarbon from the Base Chemicals & Materials cluster to
discontinued operations as well as the reclassification of DSM's
participation in Noordgastransport from Other activities to
discontinued operations. These reclassifications follow on the
announced intended disposals of these businesses.
The comparative figures can be found in the annex to this press
release and can also be downloaded from the Investors section on the
DSM corporate website, www.dsm.com.
DSM - the Life Sciences and Materials Sciences Company
Royal DSM N.V. creates innovative products and services in Life
Sciences and Materials Sciences that contribute to the quality of
life. DSM's products and services are used globally in a wide range
of markets and applications, supporting a healthier, more sustainable
and more enjoyable way of life. End markets include human and animal
nutrition and health, personal care, pharmaceuticals, automotive,
coatings and paint, electrical and electronics, life protection and
housing. DSM has annual net sales of EUR 9.3 billion and employs some
23,500 people worldwide. The company is headquartered in the
Netherlands, with locations on five continents. DSM is listed on
Euronext Amsterdam. More information: www.dsm.com
For more information:
DSM Corporate Communications DSM Investor Relations
Herman Betten Hans Vossen
tel. +31 (0) 45 tel. +31 (0) 45 5782864
5782017 fax +31 (0) 45 5782595
fax +31 (0) 45 e-mail
This announcement was originally distributed by Hugin. The issuer is
solely responsible for the content of this announcement.